This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,929.48 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 15, 2024.
The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/13/25, 9:12 AM